Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Main Capital and Aunetic in connection with the acquisition of Qnister
Mandate

Vinge advises Main Capital and Aunetic in connection with the acquisition of Qnister

October 25, 2024 Employment and Benefits M&A Data protection and processing of personal data Intellectual Property Commercial Agreements

Vinge has advised Aunetic, a leading governance software specialist, in connection with the acquisition of Qnister AB (“Qnister”). The strategic acquisition enhances Aunetic’s product portfolio and strengthens its presence in the Swedish software compliance market.

Founded in 2017, Qnister is as a SaaS-company specialising in compliance software solutions, providing GDPR and whistleblowing solutions as well as services in sanctions screening and contract management to small and medium-sized enterprises in the private sector and to customers within the public sector.

The acquisition aligns with Aunetic’s goal to expand its compliance software suite and market reach, positioning Aunetic as a leading governance software group in Europe.

Vinge’s team mainly consisted of Filip Öhrner, Linus Adolfsson, Jonatan Stentorp (M&A), Emil Lindwall, Gulestan Ali (Employment), Carla Håkansson (Commercial Agreements & GDPR), Ian Jonson (IP) and Gabriella Balbo (Transaction Support Coordinator).

Related

Vinge has advised Hansa Biopharma in connection with entering into a financing agreement

 Vinge has advised Hansa Biopharma AB (publ), a commercial-stage biopharmaceutical company on a mission to develop and commercialize innovative, lifesaving and life-altering treatments for patients with rare immunological conditions, listed on Nasdaq Stockholm, in connection with a U.S. convertible note purchase agreement comprising USD 30 million aggregate principal amount of unsecured convertible senior notes.
March 23, 2026

Vinge advises in connection with data center provider EcoDataCenter’s tap issue of SEK 500 million bonds

 Vinge has advised in connection with EcoDC Holding AB (publ)'s tap issue of SEK 500 million senior unsecured bonds under the existing framework of up to SEK 2 billion.
March 19, 2026

Vinge has advised Cinclus Pharma in connection with entering into financing agreement

 Vinge has advised Cinclus Pharma Holding AB (publ), a late-stage clinical pharmaceutical company developing next-generation treatments for gastric acid-related diseases listed on Nasdaq Stockholm, in connection with a long-term structured credit agreement for a total of up to EUR 28 million divided into four tranches, of which two are convertibles.
March 16, 2026